[
  {
    "ts": "2025-09-25T16:41:07+00:00",
    "headline": "Guardant Health (GH) Stock Trades Up, Here Is Why",
    "summary": "Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook at its investor day. The partnership aimed to make Guardant's Shield blood-based cancer screening test more widely available to physicians and patients in the United States. During its investor event, the company also revealed it accelerated its timeline for reaching cash flow breakeven by about 12",
    "url": "https://finance.yahoo.com/news/guardant-health-gh-stock-trades-164107136.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "1ad2d983-3306-3525-9ebb-b2520a1e3d58",
      "content": {
        "id": "1ad2d983-3306-3525-9ebb-b2520a1e3d58",
        "contentType": "STORY",
        "title": "Guardant Health (GH) Stock Trades Up, Here Is Why",
        "description": "",
        "summary": "Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook at its investor day. The partnership aimed to make Guardant's Shield blood-based cancer screening test more widely available to physicians and patients in the United States. During its investor event, the company also revealed it accelerated its timeline for reaching cash flow breakeven by about 12",
        "pubDate": "2025-09-25T16:41:07Z",
        "displayTime": "2025-09-25T16:41:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/dbf7d50ec8a24a514ad730aaad5be1d0",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/etQdlvewcawHBqJ9cp3yFA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/dbf7d50ec8a24a514ad730aaad5be1d0.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QxSg4mPTX8pnuk7KN_JRJQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/dbf7d50ec8a24a514ad730aaad5be1d0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/guardant-health-gh-stock-trades-164107136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/guardant-health-gh-stock-trades-164107136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GH"
            },
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-25T14:21:00+00:00",
    "headline": "Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant",
    "summary": "Quest Diagnostics, DaVita, Addus HomeCare, and The Pennant Group are positioned to benefit from telehealth, AI adoption, and rising demand in the $747B home healthcare market.",
    "url": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-quest-142100603.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9934ff86-c8cf-3298-9088-9e7d35eaa5ee",
      "content": {
        "id": "9934ff86-c8cf-3298-9088-9e7d35eaa5ee",
        "contentType": "STORY",
        "title": "Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant",
        "description": "",
        "summary": "Quest Diagnostics, DaVita, Addus HomeCare, and The Pennant Group are positioned to benefit from telehealth, AI adoption, and rising demand in the $747B home healthcare market.",
        "pubDate": "2025-09-25T14:21:00Z",
        "displayTime": "2025-09-25T14:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2fLjSeGpHAp4pnNFR6egw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qPY9mhd4gwuyP0ATgGKKxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-quest-142100603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-quest-142100603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "DVA"
            },
            {
              "symbol": "ADUS"
            },
            {
              "symbol": "PNTG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-25T14:00:00+00:00",
    "headline": "Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial results on Tuesday, October 21, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-release-third-quarter-140000576.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1a72391f-dd01-3106-86ab-3b35d0443001",
      "content": {
        "id": "1a72391f-dd01-3106-86ab-3b35d0443001",
        "contentType": "STORY",
        "title": "Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025",
        "description": "",
        "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial results on Tuesday, October 21, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
        "pubDate": "2025-09-25T14:00:00Z",
        "displayTime": "2025-09-25T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "questhealth.com logo (PRNewsfoto/Quest Diagnostics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v6s3D2c6OzmZrj.0kIY12Q--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFrizODjj_bBgmzRgIgaqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-release-third-quarter-140000576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-release-third-quarter-140000576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]